I don't think we could really be heading into a better year for BOT than 2024:
- biotech on fire
- signs of global inflation curbing
- interest rates to start dropping in 2024
- imminent FDA approval for Sofdra
I think once 2023 is out of the way, we're going to start seeing some serious attention paid to BOT.
Bot Chart, page-10570
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.8¢ |
Change
0.003(0.77%) |
Mkt cap ! $592.7M | |||
| Open | High | Low | Value | Volume |
| 32.5¢ | 33.5¢ | 32.5¢ | $1.194M | 3.642M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 46484 | 35.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 1801 | 1 |
View Market Depth
| Last trade - 15.59pm 11/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |